InnovAge
INNV
#6657
Rank
A$1.02 B
Marketcap
A$7.57
Share price
-2.33%
Change (1 day)
1.97%
Change (1 year)

Operating Margin for InnovAge (INNV)

Operating Margin as of December 2025 (TTM): -2.35%

According to InnovAge's latest financial reports and stock price the company's current Operating Margin is -2.35%. At the end of 2024 the company had an Operating Margin of -2.86%.

Operating Margin history for InnovAge from 2020 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-2.86%-61.3%
2023-7.38%612.62%
2022-1.04%-81.11%
2021-5.48%-187.27%
20206.28%15.22%
20195.45%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
AcelRx Pharmaceuticals
ACRX
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
14.06%-698.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Cocrystal Pharma
COCP
-478.64% 20,267.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-1,421.70%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.